T80.A0XA Non-ABO incompatibility reaction due to transfusion of blood or blood products, unspecified, initial encounter

Name of the Condition

• Non-ABO incompatibility reaction due to transfusion of blood or blood products, unspecified, initial encounter.

Summary

This condition describes an adverse reaction resulting from the transfusion of blood or blood products that is not due to ABO blood group incompatibility. It occurs when the recipient’s immune system reacts to non-ABO antigens in the transfused material, leading to clinical manifestations that may range from mild to severe. The "initial encounter" designation indicates this is the first time the patient is being seen for this specific reaction.

Causes

Non-ABO incompatibility reactions can be triggered by immune responses to minor blood group antigens (e.g., Rh, Kell, Duffy, or Kidd systems) or antibodies against platelet or plasma proteins. These reactions may result from prior sensitization through pregnancy, previous transfusions, or organ transplants, where the recipient has developed antibodies against these antigens.

Risk Factors

• Prior exposure to incompatible blood products
• History of multiple transfusions or pregnancies
• Underlying immune-mediated conditions
• Use of blood products with non-ABO antigen mismatches
• Lack of pre-transfusion antibody screening in high-risk patients

Symptoms

• Fever, chills, or rigors
• Skin reactions (rash, urticaria, or flushing)
• Respiratory distress (wheezing, shortness of breath)
• Hypotension or tachycardia
• Hemolysis (evidenced by dark urine or jaundice)
• Renal impairment or oliguria

Diagnosis

Diagnosis involves correlating clinical symptoms with transfusion history, performing laboratory tests to detect hemolysis or antibody-antigen reactions, and ruling out other causes of transfusion reactions. Documentation of the transfusion event and timing of symptoms is critical for establishing the diagnosis.

Treatment Options

Treatment focuses on managing symptoms and supporting the patient. This may include stopping the transfusion, administering antihistamines or corticosteroids for allergic reactions, and providing supportive care for hemolysis or renal impairment. Severe cases may require intensive monitoring or additional interventions.

Prognosis and Follow-Up

Prognosis depends on the severity of the reaction and promptness of treatment. Most mild cases resolve with appropriate care, while severe reactions may lead to complications. Follow-up typically involves monitoring for delayed reactions and ensuring the patient’s blood type and antibody status are updated for future transfusions.

Complications

• Acute kidney injury or renal failure
• Severe hemolysis leading to anemia
• Respiratory distress or shock
• Disseminated intravascular coagulation (DIC)
• Long-term sensitization to blood antigens

Lifestyle & Prevention

• Ensure accurate blood typing and crossmatching before transfusions.
• Use leukoreduced or washed blood products in high-risk patients.
• Document all transfusion reactions and update patient records accordingly.
• Educate patients on the importance of reporting prior transfusion reactions.

When to Seek Professional Help

Seek immediate medical attention if symptoms such as severe shortness of breath, chest pain, or signs of shock (e.g., pale skin, rapid pulse) occur during or after a transfusion. Delayed reactions should also be evaluated promptly.

Tips for Medical Coders

This code (T80.A0XA) is used for the initial encounter of a non-ABO incompatibility reaction due to transfusion of blood or blood products, unspecified. Documentation should clearly indicate the reaction type, transfusion event, and that this is the first encounter. Ensure the "initial encounter" status is supported by clinical notes and that the reaction is not attributed to ABO incompatibility.